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Summary 
Epidermal Langerhans cells (LC) are considered direct yet immature precursors of dendritic cells 
(DC) in the draining lymph nodes. Although the development of LC into potent immunostimu- 
latory DC occurs in vitro and has been studied in detail, little is known about their profile of 
cytokine gene expression.  By using reverse transcriptase polymerase chain reaction analysis to 
screen 16 cytokines followed by Northern blotting for selected analysis, we determined the cytokine 
gene expression profile of routine LC at different time points in culture when T cell stimulatory 
activity is increasing profoundly. LC regularly expressed macrophage inflammatory proteins, MIP-lo~ 
and MIP-2, and interleukin lfl (Ibl~). Both M1Ps were downregulated upon culture and maturation 
into DC, whereas IL-1/~ was strongly upregulated in culture. MIP-loL and Iblfl mRNA were 
found only in LC, but not in other epidermal calls. Apart from trace amounts of IL-6 in cultured 
LC, several macrophage and T cell products were not detected. The cytokine expression profile 
of LC thus appears distinct from typical macrophages. The exact role of the cytokine genes we 
found transcribed in LC remains to be determined. 
D 
endritic cells (DC) represent a distinct system of MHC 
class II positive leukocytes that  function to  initiate 
primary T cell responses (for review see reference 1). DC are 
found in nonlymphoid as well as in lymphoid tissues. Epi- 
dermal Langerhans cells (LC) are the most extensively charac- 
terized nonlymphoid DC (for reviews see references 2 and 
3). Studies of LC suggest that DC in nonlymphoid organs 
are actually immature precursors of the DC in the lymphoid 
tissues.  There is evidence that LC can leave the epidermis, 
move via the afferent lymph, and give rise to the DC found 
in the draining lymph nodes (for reviews see references 1 and 
2). The maturation of LC into potent immunostimulatory 
DC can be studied in vitro, and has been shown to occur 
upon short-term culture in response to GM-CSF and ILl 
(for reviews see references 1 and 2). This in vitro model of 
LC maturation seems to closely mimic events in situ as changes 
that occur in vitro, notably the marked upregulation of ex- 
pression of MHC class II products and the increase in stimula- 
tory activity, also occur in vivo with transplantation (4). Al- 
though a good deal has been learned about the response of 
LC to exogenous cytokines (5), it has not been determined 
what range of cytokines LC themselves produce (for review 
see reference 6). It is only known that enriched fractions of 
human LC secrete II~1 activity (7) and, after stimulation by 
LPS and PMA, TNF-ol as well (8). In addition, it was demon- 
strated recently by depletion experiments that murine LC were 
the source of IL-1B mKNA in epidermal cell (EC) suspen- 
sions (9). Information on the cytokine pattern of LC is scarce 
because of the difficulties in purifying this trace (1-3%  of 
all EC) cell population. Since this information is important 
to understand the function of LC, we have separately com- 
pared highly enriched LC with keratinocytes,  using reverse 
transcriptase PCR for screening followed by Northern blot- 
ting for further analysis. This approach allowed us to study 
the cytokine gene expression profile of LC at various stages 
of their maturation into DC.  Our major findings are that 
LC express a distinct profile of cytokine genes, and that these 
are regulated differentially  in culture. 
Materials and Methods 
Mice.  Specific  pathogen-free BALB/c (H-2  d) mice (6-12-wk- 
old of both sexes) were obtained from Charles River Wiga GmbH 
(Sulzfeld, Germany). 
Preparation of  Purified LC and LC-depleted Fractions.  EC suspen- 
sions (containing  1-3% LC) were prepared  from ear skin and treated 
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treatment removes the dendritic TCR 3'/~ bearing Thy-1 + EC, 
as well as the majority of suprabasal keratinocytes that express low 
amounts of Tby-1 antigen, and results  in an EC suspension  con- 
taining about 15% LC (5). LC were further enriched by panning 
(see below) right away as well after 12 or 72 h of EC culture to 
obtain 0-,  12-,  and 72-h LC, respectively.  For culture, the anti- 
Tbyl/C'-treated EC were plated at a density of 20  x  106 cells in 
100-mm petri dishes (No. 3003;  Falcon Labware Oxnard, CA) in 
15-ml medium RPMI 1640 supplemented with 10% FCS ([56~ 
0.5 h; Seromed, Biochrom KG, Berlin, Germany]; 1 mM t-gluta- 
mine; 5  x  10 -s M 2-ME; and 50/zg/ml gentamicin sulfate).  12- 
h LC were obtained by panning directly from 12-h nonadherent 
fractions. To obtain 72-h LC, the nonadherent fractions, which con- 
tain virtually all the LC, were removed from the petri dishes after 
72 h, and floated on dense albumin columns as described (5). LC 
were then panned from the floating fraction which contained all 
the LC at 50-80% purity. 
To determine the cytokine gene expression  of LC, we had to 
devise a strategy that would allow us to enrich I.C to virtually 100% 
yet save the LC-depleted fractions for simultaneous analysis to con- 
trol  for inevitable  minor  crosscontamination.  To  this  end  we 
modified our panning technique (5) (yield:  8-10  x  104 fresh or 
cultured LC/2 mouse ears) taking into account that panned LC 
could be lysed for RNA preparation while still attached to the petri 
dish. EC fractions were, therefore, treated with two rather than 
just one mAb reactive with LC. We used anti-I-E  k,a (clone 14-4- 
4S, mouse IgG2a, HB32 from the American Type Culture Collec- 
tion (ATCC, Kockville, MD) plus anti-I-A  b'd mAb (clone B 21-2, 
rat IgG2b, TIB 229 from the ATCC) or, alternatively,  in some ex- 
periments, antileukocyte common antigen (clone M 1/9, rat Ig2a, 
TIB 122 from the ATCC). EC were then panned on petri dishes 
coated with nonspecies specific goat anti-mouse Ig for 30 min on 
ice and for 5 rain at room temperature (without adding competing 
mouse or rat Ig which are needed to detach LC by washing [5]). 
Nonadherent cells were then removed by washing until careful 
monitoring under the inverted phase-contrast revealed that only 
LC were left behind. LC could be easily identified by their cell sur- 
face processes which appeared spread out on the petri dish. At most 
two non-LC among 100 cells were detectable.  This degree of en- 
richment (>98% LC) was confirmed in pilot experiments where 
the attached ceils were stained  with FITC-anti-I-A  b.d to identify 
LC by immunofluorescence as well. The nonadherent fraction was 
transferred to another anti-mouse Ig-eoated petri dish and panned 
for another 15 min at room temperature to remove any residual 
LC. Contaminating LC were not detectable by flow cytometry 
(staining with FITC-anti-I-A  b,d as described [5]). 
Besides the non-LC fractions left after panning,  we also used 
EC that were not Thyl-depleted for RNA isolation. Freshly pre- 
pared EC were either treated with isotype-matched control Ab and 
complement, or depleted of LC by anti-Ia/C' treatment followed 
by panning, and studied right away or after 12-72 h of culture. 
Preparation of RNA and eDNA.  Total cellular RNA was iso- 
lated by the guanidinium isothiocyanate/cesium chloride method 
as described  (5).  LC were lysed while still  attached to the petri 
dishes used for panning by adding lysis buffer (4 M guanidinium 
isothiocyanate, 5 mM sodium citrate, 0.5 % N-lauroylsarcosine so- 
dium salt, 100 mM 2-ME). Lysates were subjected to cesium chlo- 
ride gradient centrifugation. After butanol-chloroform extraction 
and precipitation in ethanol, the concentration of KNA was mea- 
sured by Az60 absorption.  5 #g of total cellular RNA  (with or 
without prior treatment with RNAse-free DNAse [Promega Corp., 
Madison, WI]) were reverse transcribed using a cDNA cycle kit 
(Invitrogen Co., San Diego, CA) in a final reaction volume of 50 
/zl. 2 #1 of this cDNA reaction mixture (representing 200 ng tran- 
scribed  RNA  derived from 2  x  10  s I.C)  were used  for PCR 
amplification. 
PCR Conditions.  PCR primer pairs were purchased (Clontech, 
Palo Alto, CA) except for IFN-c~ (5' primer: 5'-AATGACCTCC- 
ACCAGCAGCT-3';  3-primer: 5'-TCTCAGGTACACAGTGATCC- 
3'; size of amplified fragment: 137 bp; kindly provided by Dr. R. 
Zawatzky, German Cancer Center, Heidelberg, Germany), IFN-3 
(5'-primer:  5'-GAAAAGCAAGAGGAAAGATT-3';  3'-primer: 
5'-AAGTCTTCGAATGATGAGAA-3'; amplified fragment:  165 bp; 
kindly provided by Dr.  R.  Zawatzky),  and  MIP-2  (5'-primer: 
5'-TCTTCCTCGGGCACTCCAGA-Y;  3'-primer:  5'-GGACA- 
GCAGCCCAGGCTCCT-3'; amplified fragment: 379 bp; kindly 
provided by Dr. B. Sherry, The Rockefeller University,  New York, 
NY). 2 #1 of cDNA were amplified in a final volume of 50 I~1 in 
the presence of 1/zM final concentration of 5' and 3' primers, and 
PCR master mix (200/zM dNTPs, 1 U ofTaq polymerase (Promega 
Corp.), 50 mM Tris-HC1 (pH 8.5), 5 mM MgC12, 50 mM NaC1, 
and 2 mM DTT. The reaction mixture was overlaid with a drop 
of sterile paraffin oil, and the PCR was performed in a DNA thermal 
cycler (Thermocycler 60/2; Bio-Med, Theres, Germany) for 30 cycles 
(1 min denaturation at 94~  2 min annealing at 60~  3 min ex- 
tension time at 72~  and a delay time of 7 rain for the last step). 
16 #1 of the reaction mix were removed and separated at 60 V for 
2 h in 1% agarose in lx  TBE buffer containing 0.5/~g/ml ethidium 
bromide. 1 Izg of a 1-kb and a 123-bp DNA ladder  (BRL Gibco, 
Gaithersburg, MD) were run in parallel as molecular weight markers. 
An UV transilluminator was used to view and photograph the gels. 
Ten independent experiments were performed with comparable 
results.  Before each PCR amplification of LC-derived cDNA, we 
performed positive controls using templates (Clontech) as well as 
a constant batch of RNA we had prepared from restimulated T 
ceUs and LPS-stimulated peritoneal macrophages.  Negative con- 
trols were included with each experiment (no eDNA =  no cDNA, 
but actin primers added; no RT  =  RNA "reverse transcribed" in 
the absence of reverse transcriptase plus IFN-c~ or actin primers 
added).  Specificity of the amplified bands was validated by their 
predicted size. For those cytokine genes that were found expressed 
in LC we also performed the PCR procedure described by Dallman 
et al. (10) to demonstrate specificity and to ensure that at the 30 
cycles we used we had not passed the plateau of amplification.  To 
this end, 10/~1 of eDNA were used in the PCR and 15/~1 of the 
amplification  mix were removed every five cycles from 15 or 20 
up to 50 cycles. PCR products were analyzed by gel electropho- 
resis or dot-blotted to Hybond-N + membrane (Amersham Corp., 
Arlington Heights, IL) and probed using 32P-end-labeled internal 
oligos [ILlfl: 5'-GAGCCTGTAG~GCTG~FCTAATC,  GGAAC-3'; 
II.,6: 5'-CTCCA~~TACTCCAGAAGACC-3';  MIP-I~. 
5 '-  GACACCTGGCTGGGAGCAAAGGCTC,  CTGGT-3  '; MIP-2: 
5 '-CAGGGTCTTCAGGCATTGACAGC  GCAGTTC-  3']. 
Northern Blotting.  To confirm the results  obtained by PCR 
screening we performed Northern blotting (10-15/~g total cyto- 
plasmic RNA per lane) exactly as described (5) using eDNA probes 
for murine IL-1B (provided by Dr. P.  W.  Gray, Genentech Inc., 
South San Francisco, CA [11]), IL-6 (provided by Dr. F. Lee, DNAX 
Research  Institute of Molecular and Cellular Biology, Palo Alto, 
CA [12]), MIP-loe (provided by Dr. G. J. Graham, The Beatson 
Institute for Cancer Research,  Glasgow,  UK)  (13), and MIP-2 
(provided by Dr. P. Tekamp-Olson, Chiron Co., Emeryville, CA 
[14]). For MIP-lot we also used 32p-labeled RNA probes prepared 
from coding sequences of SCI/MIP-I~ (13) using standard tech- 
niques. Northern blotting experiments require the use of  200 mouse 
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LC. 
Results 
PCR Analysis of Cytokine mRNA Expression  in Langerhans 
Cells.  By using the reverse transcriptase PCR technique we 
found that 4 out of 16 tested cytokines were detectable in 
LC-enriched (>98%)  fractions.  We reproducibly obtained 
strong IL-13--specific bands with 72-h LC-fractions, whereas 
bands with 12- and O-h LC were usually weaker and in some 
experiments were even absent in O-h LC (compare Figs.  1 
and 2). It is interesting that IL-loe was not detectable in LC 
(Figs.  1-3).  IL-6 mRNA was not found in 0- or 12-h  LC, 
whereas 72-h LC yielded IL-6-specific  bands,  which were, 
however, faint (Fig.  2) to barely detectable (Fig.  1). MIP-lo~ 
was regularly and dearly expressed only by fresh LC (Fig. 
1).  MIP-2-specific bands of variable intensity were detect- 
able in O- and 12-h as well as 72-h LC. Simultaneous analysis 
of LC-depleted  fractions  showed  that  I1.-1/5 and  MIP-loe 
mRNAs were usually absent,  indicating that keratinocytes 
do not transcribe these cytokine genes. Ib6 was found in 0- 
and 12-h I.C-depleted fractions but was not detectable in 72-h 
LC-depleted fractions. MIP-2 was variably expressed by non-I.C 
fractions. As LC-depleted fractions obtained after panning 
represent only a subset of EC (see Materials and Methods), 
we also  analyzed EC that had not been treated with anti- 
Thyl and C'.  Such EC (mainly keratinocytes) expressed the 
expected range of cytokines such as IL-lol, TNF-cx, GM-CSF, 
etc. We found that any detectable Ib1/5 or MIP-lcc-specific 
bands disappeared after removal of LC by anti-Ia/C'  treat- 
ment and panning, whereas MIP-2-specific bands were still 
present (data not shown). This demonstrated that LC even 
among unseparated EC are the only source of IL-1/3 and MIP- 
loe. MIP-2 mRNA was detectable by PCR in fresh as well 
as cultured EC even after depletion of LC. In contrast, Ib6 
mRNA was found in 0- and 12-h EC even after LC deple- 
tion, but was not invariably detectable in cultured and LC- 
free EC  (data not shown). 
Northern Blot Analysis of Cytokine mRNA  Expression in 
Langerhans Cells.  As limiting amounts of RNA (10 #g LC- 
RNA/200 mouse ears) prohibited the use of RNase protec- 
tion  assays or poly(A  +)  RNA,  we used total cytoplasmic 
RNA and Northern blot analysis  to extend our PCK data 
for selected cytokine mRNAs.  Northern blotting demon- 
strated that IL-1/5 mRNA is massively  upregulated in LC after 
culture (Fig.  4). We were unable to detect II,-6 mRNA ex- 
pression in I_C or EC by Northern blot analysis  even after 
6-d film exposure (Fig. 5 A). Northern blotting using a MIP- 
loc cDNA probe either yielded no signal or a very weak band 
with fresh LC (Fig. 5 B), yet MIP-lot mRNA was more clearly 
shown to be expressed by fresh LC when blots were probed 
with a 32p-labeled RNA probe (Fig.  6).  Freshly isolated LC 
contained much more MIP-2 mRNA than cultured ones (Fig. 
5 C). LC-depleted EC expressed MIP-2, but less than either 
fresh or cultured LC (Fig.  5  C). 
Figure  1.  PCR analysis ofcyto- 
kine gene expression in LC. LC were 
enriched (>98%) by panning from 
freshly prepared, 12- and 72-h cul- 
tured Thy-l-depleted EC (0-, 12-, 
and 72-h LC). RNA was prepared 
from LC-enriched and LC-depleted 
fractions (nonadherent fractions ob- 
tained after panning, non-LC), re- 
verse transcribed and mRNA  ex- 
pression analyzed by PCR (IL-lot, 
ID1B, I1r162  TNF-a, TNF-B, 
GM-CSF, IFN-ot, IFN-B, IFN-% 
IL-2 receptor, TGF-~, CD4, CDS, 
B2 microglobulin, MIP-loL, MIP-2, 
no cDNA control, actin,  no  KT 
control  [see  Materials  and  Me- 
thodsl). Note that IL-1B mRNA 
signal appears  in  12-h  LC  and is 
strong in 72-h  LC,  but  is absent 
from non-I.C. IL-I~ is not expressed 
by LC fractions, but an IL-lot specific 
band (open white arrow) is expressed 
by 12-h non-LC. II.-6 is absent from 
I.C except for a very faint band in 
72-h LC. MllXlot mRNA is dearly 
detectable  in  O-h  I.C  fractions, 
whereas  12-h  I/2 display  only  a very 
faint  band, and 72-h LC none  at all. 
MIP-2 is expressed  by all I.C frac- 
tions. For further details see text. 
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from an experiment identical to the one outlined in Fig. 1 demonstrate 
the variability  of  IL-13  and II-6 expression  by LC. Note that in this experi- 
ment 0-h LC score  clearly  positive  for IL,13 (lane  2), and 72-h LC generate 
an unequivocal IL-6 signal (lane 7) (compare with Fig. 1). 
Figure  5.  Northern blot analysis of IL-6, MIP-lc~,  and MIP-2 mRNA 
expression in LC and EC. The blot was probed with 32p-labeled IL-6 
eDNA (A), MIP-lo~  eDNA (B; arrowhead denotes barely visible MIP-lc~ 
transcript), and MIP-2 (C). Lanes 1, 0-h LC; 2, 72-h LC; 3, 0-h non-LC 
(see Fig. 1); 4, LC-depleted EC cultured for 72 h; 5, peritoneal macro- 
phages; and 6, LPS-stimulated  peritoneal macrophages (10/~g/ml, 8 h). 
(D) Ethidium bromide staining of  gels (15 ~g RNA/lane). Film exposure 
was for (+4) 3 and 6 d (only 3 d is shown); (B) 3 and 6 d (only 6 d is 
shown); and (C) 3 d. 
Figure 3.  PCR-assisted  mlLNA amplification  demonstrates  absence  of 
Iblo~ in LC. eDNA samples were cycled  through 50 cycles  of PClk. 15 
/~1 of the amplification  mix were removed every five cycles  and analyzed 
by gel electrophoresis. Note that 72-h LC-free EC (72-h keratinocytes) 
display an IL-lc~-specific  amplification  fragment that is, however, absent 
from 72-h LC even at 50 cycles. Identical results were obtained with 0-h 
LC (data not shown).  Figure 6.  Northern blot anal- 
ysis of MIP-lc, mRNA expression 
in 0-h LC. 15/~g  total cytoplasmic 
ILNA derived from 0-h LC was 
hybridized  with  a  32p-labeled 
MIP-l~-sprciiic  RNA probe. (*-) 
marks  the  MIP-lo~ transcript. 
(mmm) 18 and 28S rRNA. 
Figure 4.  Northern blot analysis of IL-1/8 mRNA expression in LC 
and EC. Hybridization with a 32p-labeled  Ibl~ eDNA probe (2-d film 
exposure) reveals some IL-13 mRNA in 0-h LC (lane 1), much more in 
72-h LC (lane 2), but none in lanes 3 (0-h non-LC; see Fig. 1), 4 (72-h 
non-LC; see Fig. 1), 5 (fresh EC), 6 (fresh, LC-depleted EC), or 7 (LC- 
depleted EC cultured for 72 h). Ethidiumbromide-stained  gels show in- 
tegrity and loading (10/~g/lane) of RNA. (mmm) 18 and 28S rRNA. 
Taken together, our data demonstrate that freshly isolated 
LC contain MIP-lo~ mRNA and substantial amounts of MIP-2 
transcripts,  whereas  cultured  LC express large  amounts  of 
IL-I~, yet little  II.,6  mRNA.  Only LC but  not  other EC 
(primarily keratinocytes) produce IL-1B and MIP-loe mRNA. 
LC undergo  major changes  in morphology,  phenotype, 
and function when they develop into potent immunostimula- 
tory DC  during  short-term culture (15).  For example,  an- 
tigen processing and T  cell sensitizing functions are recipro- 
caUy expressed in fresh versus cultured LC (3, 16, 17). When 
we set out to study the cytokine gene expression of LC it 
was, therefore, crucial to examine LC at various stages of their 
maturation into DC. It also appeared essential to study highly 
enriched populations of LC, even though purification of this 
trace cell population is dif~cult, time-consuming and costly, 
rather than just  simply  to examine EC  suspensions  before 
and after depletion of LC.  One reason was  that  only such 
an approach when combined with the highly sensitive PCR 
analysis would allow one to detect cytokine mRNAs present 
in low copy numbers and/or subsets of LC. Another reason 
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if the respective cytokine was expressed by LC as well as other 
EC. Indeed, in a recent study (9), only keratinocytes but not 
LC were thus identified as a source of MIP-2. 
We found that four cytokine genes were expressed by LC 
and fell into two differentially regulated groups. Two of the 
cytokines, namely IL-13 and MIP-lot, were selectively expressed 
by LC but not by other EC. IL-13 appeared to be gradually 
but strongly upregulated during the 3-d culture period. II.-6 
mRNA was detectable only in 72-h LC and only by PCR 
but not Northern blot analysis,  which indicates that only 
few ID6 transcripts were present. Recent in situ hybridiza- 
tion experiments using digoxigenin-labeled IL-6-specific an- 
tisense oligonucleotide probes indeed show that IIr  is ex- 
pressed only by a variable subset of 72-h LC (unpublished 
data). MIP-lc~ was weakly and MIP-2 quite strongly expressed 
by fresh LC, but both were downregulated upon culture. The 
kinetics of cytokine gene expression by LC is thus remark- 
ably different from that of typical macrophages that one would 
not expect to differentially regulate the cytokines I/--1/3, IL6, 
MIP-lot and 2. Unlike macrophages, LC also did not express 
such genes as Iblc~, IFNot, and GM-CSF. We suspect that 
the LC cytokine gene expression profile that we observe during 
culture, particularly the gradual yet massive upregulation of 
Ibl~, is inherent to the maturation of LC into potent stimula- 
tory DC, and not simply caused by exposure to trace amounts 
of LPS.  In this context it is certainly notable that murine 
spleen DC, which like cultured LC are mature DC, lack II:lot 
mRNA even after massive LPS  stimulation  (as shown by 
Northern blotting) (18), but express Ib13 (our own unpub- 
lished  results)just  like  LC.  Whether  LC  would  express 
cytokine genes like Iblot,  IFNot, or GM-CSF after exoge- 
nous LPS  stimulation has yet to be determined using ap- 
proaches such as in situ hybridization. We tried to analyze 
the response of LC to LPS by PCR analysis. We were, how- 
ever, unable to faithfully exclude that respective PCR signals 
in LC fractions were not due to small numbers of contamin- 
ating keratinocytes, as LPS caused a strong upregulation of 
cytokine gene expression in keratinocytes (unpublished data). 
The translation of the four cytokines in LC, their expres- 
sion in vivo, as well as their role, remain to be determined. 
The data obtained so far, however, already raise several in- 
teresting issues and provide a guideline for further studies. 
LC might participate in inflammatory reactions via secretion 
of II~1~,  1I.-6, MIP-lc~,  and MIP-2,  all of which represent 
proinflammatory cytokines. It will be particularly interesting 
to explore the potential roles of MIP-lol molecules. One in- 
triguing possibility is that MIP-lol acts as a paracrine regu- 
lator of epidermal homeostasis since MIP-lot has recently been 
shown to act as an inhibitor of bone marrow (13) as well 
as keratinocyte stem cells (Parkinson, E. K., G. J. Graham, 
P. Daubersies, J. E. Burns, C. Heufler, M. Plumb, G. Schuler, 
and I. B.  PragneU,  manuscript in preparation).  It will also 
be interesting to assess whether MIP-lc~ modulates LC func- 
tion inasmuch as MIP-1 peptides can act as autocrine modu- 
lators of their cell of origin (19). 
The cytokine gene expression pattern which we find after 
preparation of EC and isolation of LC is likely induced rela- 
tive to the epidermis in situ since we do not detect any cytokine 
mRNA by PCR analysis of heat-separated (55~  for 30 s), 
normal epidermis (unpublished data). As outlined in the in- 
troductory paragraph, the maturation of LC during culture 
of EC seems to closely mimic events in situ (4), and this seems 
to hold true for the cytokine gene expression profile of LC 
as well. In a recent study on the cytokine expression of EC 
in the induction phase of contact hypersensitivity (9), a mas- 
sive upregulation of IL-lj8 was noted after epicutaneous ap- 
plication of contact allergens, but not after application of 
tolerogens, nonsensitizers, or irritants. LC were identified as 
the source of ILIB mRNA amongst EC by depletion ex- 
periments. Our study now allows an interpretation of these 
interesting findings, since our data strongly suggest that the 
upregulation of II.,lj8 mRNA is actually due to the matura- 
tion of LC into DC during the induction phase of contact 
hypersensitivity.  We are currently investigating how the matu- 
ration of LC into potent immunostimulatory DC is induced, 
and what role the massive expression of IL-1B might play 
for the function of LC. 
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